Further to its letter dated August 24, 2022 and pursuant to Regulation 30 of the Listing Regulations, Glenmark Pharmaceuticals has informed that it enclosed the Notice and Explanatory statement Convening the 44th Annual General Meeting (AGM) scheduled to be held on Tuesday, September 27, 2022 at 2.00 pm IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The notice of AGM is being sent to all the members whose email Ids have been registered with the Company. The Company is to provide to its members the facility to exercise their right to vote on the resolutions proposed to be passed at the AGM by electronic means. Only Shareholders, whose name is recorded in the register of members or in the register of beneficial owners maintained by the depositories as on the cut-off date, Tuesday, September 20, 2022, shall be entitled to avail thee-voting facility. The remote e-voting facility commences on Saturday, September 24, 2022 from 9.00 am (IST) and ends on Monday, September 26, 2022 at 5.00 pm (IST).
The above information is a part of company’s filings submitted to BSE.
